CorMedix

 

Home About CorMedix Pipeline News Investor Relations Contact Us
CorMedix

Overview
Management Team
Scientific Advisory Board
Board of Directors

 

Cormedix

Cardiorenal Advisory Board

Our Cardiorenal Advisory Board is a panel of world-renowned physicians with special expertise in cardiorenal disease - the epidemic intersection of cardiovascular disease and renal (chronic kidney) disease. These outstanding physicians will provide the high-level critical thinking and cutting-edge expertise that CorMedix will require as we work to become the preeminent innovator in an exciting, challenging area of medicine.

The CorMedix Cardiorenal Advisory Board represents the fields of nephrology, diabetes and endocrinology, and cardiology:

Joseph Bonventre, MD, PhD

Dr. Bonventre is the Robert H. Ebert Professor of Medicine at the Harvard Medical School, and is Director of the Renal Division, Brigham and Women's Hospital. He is an expert in Acute Kidney Injury, and the use of Biomarkers to define tissue injury and predict clinical outcomes.

Z. Ioav Cabantchik, M.D., Ph.D

Dr. Cabantchik is Professor of Biological Chemistry at the Hebrew University of Jerusalem, Israel. A research hematologist, Dr. Cabantchik spent his early career studying membrane transport in acid-base metabolism. Over the past decade, he has studied iron metabolism in health and disease. He is considered one of the world's foremost experts in the pathophysiology of labile or catalytic iron and iron chelation. His recent research has focused on the role of labile iron as a mediator of cellular injury in diseases of regional iron accumulation.

Vivian Fonseca, M.D.

At Tulane University Medical Center, Dr. Fonseca is a Professor of Medicine, Director of the Diabetes Program, and Tullis-Tulane Alumni Chair in Diabetes. He is a recognized expert in the prevention and treatment of diabetic complications and cardiovascular disease. He has authored or co-authored more than 200 professional publications and is Editor-in-Chief of Diabetes Care and of Journal of the Metabolic Syndrome.

Charles Herzog, M.D.

Dr. Herzog is Director of the Cardiovascular Special Studies Center, United States Renal Data System. He has been a cardiologist at Hennepin County Medical Center (HCMC) in Minneapolis. A University of Minnesota faculty member for 23 years, he has been Professor of Medicine since 2004. Since 1985 he has been the cardiology consultant to the ESRD program at HCMC (dialysis and renal transplantation). He founded the program in interventional cardiology and served as Director of the Cardiac Catheterization Laboratory at HCMC from 1985 to 1991. Since 1997 he has been Director of the HCMC Cardiac Ultrasound Laboratory. Dr. Herzog is a Fellow of the American College of Cardiology. His areas of research or special interest include cardiac disease and ESRD and echocardiography. He is a member of the editorial boards of American Heart Journal, Journal of Nephrology, and Clinical Journal of the American Society of Nephrology. He is a liaison editor (cardiology) for Nephrology Dialysis Transplantation.

Giuseppe Remuzzi, M.D.

Professor Remuzzi is Director of the Negri Bergamo Laboratories of the Mario Negri Institute for Pharmacological Research and Director of the Department of Immunology and Clinical Transplantation of the Ospedali Riuniti di Bergamo, Italy. In these positions he leads a diverse team of clinicians and researchers studying human renal diseases and experimental models for pathophysiological study and therapeutic intervention. Professor Remuzzi is recognized as an international expert in renal disease. An author or co-author of more than 920 scientific articles, he serves on the editorial boards of many journals, including the New England Journal of Medicine.

Sudhir V. Shah, M.D.

Dr. Shah is Professor of Internal Medicine and Director, Division of Nephrology at the University of Arkansas College (UAMS), where he has been on the faculty since 1990. Dr. Shah is also Chief of the Nephrology Section at the John L. McClellan Memorial Veterans Hospital. Prior to joining UAMS, Dr. Shah was on the teaching faculty in the Section of Nephrology at Tulane University School of Medicine from 1979 to 1990, most recently as Professor of Medicine. Dr. Shah has served as a member of the Pathology A Study Section of the National Institutes of Health, was Chairman of the program committee for the National Kidney Foundation, and has been on the editorial boards of Kidney International, Journal of the American Society of Nephrology, American Journal of Kidney Disease, and American Journal of Physiology. He has served as Chairman of the Acute Renal Failure Advisory Group for the American Society of Nephrology and also on the ASN Board of Advisors. He is currently President of the International Federation of Kidney Foundations.

©2011 CorMedix Inc.  

Site Map | Privacy Policy | Terms of Service